{ "labelLang" : "hun", "responseDate" : "2024-03-28 17:52", "content" : { "otype" : "JournalArticle", "mtid" : 33286383, "status" : "VALIDATED", "published" : true, "unhandledTickets" : 0, "deleted" : false, "lastRefresh" : "2024-02-20T13:17:50.985+0000", "lastModified" : "2024-01-31T08:03:31.138+0000", "created" : "2022-12-01T08:38:56.486+0000", "creator" : { "otype" : "Author", "mtid" : 10017317, "link" : "/api/author/10017317", "label" : "Bogár Ferenc (Molekulamodellezés)", "familyName" : "Bogár", "givenName" : "Ferenc", "published" : true, "oldId" : 10017317, "snippet" : true }, "lastDuplumOK" : "2024-02-27T11:10:12.248+0000", "lastDuplumSearch" : "2024-02-27T11:10:12.248+0000", "validated" : "2024-01-31T08:03:31.697+0000", "validator" : { "otype" : "Admin", "mtid" : 10078753, "link" : "/api/admin/10078753", "label" : "Kiss Fatima Jázmin (SZTE admin5)", "familyName" : "Kiss", "givenName" : "Fatima Jázmin", "published" : true, "snippet" : true }, "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 10000059, "link" : "/api/subtype/10000059", "label" : "Szakcikk (Folyóiratcikk)", "name" : "Szakcikk", "nameEng" : "Article", "docType" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "listPosition" : 101, "published" : true, "oldId" : 10000059, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Fallica, Antonino N.", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 104550477, "link" : "/api/authorship/104550477", "label" : "Fallica, Antonino N.", "listPosition" : 1, "share" : 0.11111111, "first" : true, "last" : false, "corresponding" : false, "familyName" : "Fallica", "givenName" : "Antonino N.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 104550478, "link" : "/api/authorship/104550478", "label" : "Ciaffaglione, Valeria", "listPosition" : 2, "share" : 0.11111111, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Ciaffaglione", "givenName" : "Valeria", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 104550479, "link" : "/api/authorship/104550479", "label" : "Modica, Maria N.", "listPosition" : 3, "share" : 0.11111111, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Modica", "givenName" : "Maria N.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 104550480, "link" : "/api/authorship/104550480", "label" : "Pittalà, Valeria", "listPosition" : 4, "share" : 0.11111111, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Pittalà", "givenName" : "Valeria", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 104550481, "link" : "/api/authorship/104550481", "label" : "Salerno, Loredana", "listPosition" : 5, "share" : 0.11111111, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Salerno", "givenName" : "Loredana", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 104550482, "link" : "/api/authorship/104550482", "label" : "Amata, Emanuele", "listPosition" : 6, "share" : 0.11111111, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Amata", "givenName" : "Emanuele", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 104550483, "link" : "/api/authorship/104550483", "label" : "Marrazzo, Agostino", "listPosition" : 7, "share" : 0.11111111, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Marrazzo", "givenName" : "Agostino", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 104550484, "link" : "/api/authorship/104550484", "label" : "Romeo, Giuseppe", "listPosition" : 8, "share" : 0.11111111, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Romeo", "givenName" : "Giuseppe", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 104550485, "link" : "/api/authorship/104550485", "label" : "Intagliata, Sebastiano", "listPosition" : 9, "share" : 0.11111111, "first" : false, "last" : true, "corresponding" : false, "familyName" : "Intagliata", "givenName" : "Sebastiano", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true } ], "title" : "Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 22182768, "link" : "/api/publicationidentifier/22182768", "label" : "DOI: 10.1016/j.bmc.2022.117032", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "10.1016/j.bmc.2022.117032", "realUrl" : "https://doi.org/10.1016/j.bmc.2022.117032", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 22182770, "link" : "/api/publicationidentifier/22182770", "label" : "WoS: 000876372400005", "source" : { "otype" : "PlainSource", "mtid" : 1, "link" : "/api/publicationsource/1", "label" : "WoS", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "WoS", "nameEng" : "WoS", "linkPattern" : "https://www.webofscience.com/wos/woscc/full-record/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 1, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "000876372400005", "realUrl" : "https://www.webofscience.com/wos/woscc/full-record/000876372400005", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 23084507, "link" : "/api/publicationidentifier/23084507", "label" : "Scopus: 85139238392", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "85139238392", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85139238392", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 22182769, "link" : "/api/publicationidentifier/22182769", "label" : "Egyéb URL: https://linkinghub.elsevier.com/retrieve/pii/S0968089622004254", "source" : { "otype" : "PlainSource", "mtid" : 40, "link" : "/api/publicationsource/40", "label" : "Egyéb URL", "type" : { "otype" : "PublicationSourceType", "mtid" : 10006, "link" : "/api/publicationsourcetype/10006", "label" : "Link", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "Egyéb URL", "nameEng" : "Other URL", "linkPattern" : "@@@", "publiclyVisible" : true, "published" : true, "oldId" : 40, "snippet" : true }, "idValue" : "https://linkinghub.elsevier.com/retrieve/pii/S0968089622004254", "realUrl" : "https://linkinghub.elsevier.com/retrieve/pii/S0968089622004254", "published" : false, "snippet" : true } ], "journal" : { "otype" : "Journal", "mtid" : 11300, "link" : "/api/journal/11300", "label" : "BIOORGANIC & MEDICINAL CHEMISTRY 0968-0896 1464-3391", "pIssn" : "0968-0896", "eIssn" : "1464-3391", "reviewType" : "REVIEWED", "noIF" : false, "sciIndexed" : true, "scopusIndexed" : true, "lang" : "FOREIGN", "hungarian" : false, "published" : true, "oldId" : 11300, "snippet" : true }, "volume" : "73", "internalId" : "117032", "firstPageOrInternalIdForSort" : "117032", "pageLength" : 20, "publishedYear" : 2022, "subjects" : [ { "otype" : "Classification", "mtid" : 12184, "link" : "/api/classification/12184", "label" : "Farmakológia és gyógyszerészet", "published" : true, "snippet" : true }, { "otype" : "Classification", "mtid" : 10398, "link" : "/api/classification/10398", "label" : "Gyógyszerkémia", "published" : true, "snippet" : true } ], "digital" : null, "printed" : true, "sourceYear" : 2022, "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : false, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2024-02-20", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 1, "citedCount" : 1, "ratings" : [ { "otype" : "SjrRating", "mtid" : 11284476, "link" : "/api/sjrrating/11284476", "label" : "sjr:Q2 (2022) Scopus - Clinical Biochemistry BIOORGANIC & MEDICINAL CHEMISTRY 0968-0896 1464-3391", "listPos" : 60, "rankValue" : 0.49, "type" : "journal", "ratingType" : { "otype" : "RatingType", "mtid" : 10002, "link" : "/api/ratingtype/10002", "label" : "sjr", "code" : "sjr", "published" : true, "snippet" : true }, "subject" : { "otype" : "ClassificationExternal", "mtid" : 1308, "link" : "/api/classificationexternal/1308", "label" : "Scopus - Clinical Biochemistry", "published" : true, "oldId" : 1308, "snippet" : true }, "ranking" : "Q2", "calculation" : "DIRECT", "published" : true, "snippet" : true } ], "ratingsForSort" : "Q2", "references" : [ { "otype" : "Reference", "mtid" : 36202746, "link" : "/api/reference/36202746", "label" : "1. Cobos 2008: Pharmacology and therapeutic potential of sigma(1) receptor ligands., Curr Neuropharmacol, 6, p. 344, DOI: 10.2174/157015908787386113", "listPosition" : 1, "doi" : "10.2174/157015908787386113", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202747, "link" : "/api/reference/36202747", "label" : "2. Gilbert 1976: The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog., J Pharmacol Exp Ther, 198, p. 66", "listPosition" : 2, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202748, "link" : "/api/reference/36202748", "label" : "3. Hayashi 2010: Detergent-resistant microdomains determine the localization of sigma-1 receptors to the endoplasmic reticulum-mitochondria junction., Mol Pharmacol, 77, p. 517, DOI: 10.1124/mol.109.062539", "listPosition" : 3, "doi" : "10.1124/mol.109.062539", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202749, "link" : "/api/reference/36202749", "label" : "4. Hanner 1996: Purification, molecular cloning, and expression of the mammalian sigma1-binding site., Proc Natl Acad Sci U S A, 93, p. 8072, DOI: 10.1073/pnas.93.15.8072", "listPosition" : 4, "doi" : "10.1073/pnas.93.15.8072", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202750, "link" : "/api/reference/36202750", "label" : "5. Schmidt 2019: The molecular function of σ receptors: past, present, and future., Trends Pharmacol Sci, 40, p. 636, DOI: 10.1016/j.tips.2019.07.006", "listPosition" : 5, "doi" : "10.1016/j.tips.2019.07.006", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202751, "link" : "/api/reference/36202751", "label" : "6. Hellewell 1990: A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain., Brain Res, 527, p. 244, DOI: 10.1016/0006-8993(90)91143-5", "listPosition" : 6, "doi" : "10.1016/0006-8993(90)91143-5", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202752, "link" : "/api/reference/36202752", "label" : "7. Xu 2011: Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site., Nat Commun, 2, p. 380, DOI: 10.1038/ncomms1386", "listPosition" : 7, "doi" : "10.1038/ncomms1386", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202753, "link" : "/api/reference/36202753", "label" : "8. Chu 2015: The sigma-2 receptor and progesterone receptor membrane component 1 are different binding sites derived from independent genes., EBioMedicine, 2, p. 1806, DOI: 10.1016/j.ebiom.2015.10.017", "listPosition" : 8, "doi" : "10.1016/j.ebiom.2015.10.017", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202754, "link" : "/api/reference/36202754", "label" : "9. Pati 2017: Sigma-2 receptor and progesterone receptor membrane component 1 (PGRMC1) are two different proteins: Proofs by fluorescent labeling and binding of sigma-2 receptor ligands to PGRMC1., Pharmacol Res, 117, p. 67, DOI: 10.1016/j.phrs.2016.12.023", "listPosition" : 9, "doi" : "10.1016/j.phrs.2016.12.023", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202755, "link" : "/api/reference/36202755", "label" : "10. Alon 2017: Identification of the gene that codes for the σ2 receptor., Proc Natl Acad Sci U S A, 114, p. 7160, DOI: 10.1073/pnas.1705154114", "listPosition" : 10, "doi" : "10.1073/pnas.1705154114", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202756, "link" : "/api/reference/36202756", "label" : "11. Shen 2020: BRD2 regulation of sigma-2 receptor upon cholesterol deprivation., Life Sci Alliance, 4", "listPosition" : 11, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202757, "link" : "/api/reference/36202757", "label" : "12. Zhan 2021: The sigma-2 receptor/TMEM97 agonist PB28 suppresses cell proliferation and invasion by regulating the PI3K-AKT-mTOR signalling pathway in renal cancer., J Cell Mol Med, 25, p. 11244, DOI: 10.1111/jcmm.17047", "listPosition" : 12, "doi" : "10.1111/jcmm.17047", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202758, "link" : "/api/reference/36202758", "label" : "13. Sánchez-Fernández 2014: Modulation of peripheral μ-opioid analgesia by σ1 receptors., J Pharmacol Exp Ther, 348, p. 32, DOI: 10.1124/jpet.113.208272", "listPosition" : 13, "doi" : "10.1124/jpet.113.208272", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202759, "link" : "/api/reference/36202759", "label" : "14. Kinoshita 2012: Sigma-1 receptor alters the kinetics of Kv1.3 voltage gated potassium channels but not the sensitivity to receptor ligands., Brain Res, 1452, p. 1, DOI: 10.1016/j.brainres.2012.02.070", "listPosition" : 14, "doi" : "10.1016/j.brainres.2012.02.070", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202760, "link" : "/api/reference/36202760", "label" : "15. Zhang 2017: Sigma-1 receptor plays a negative modulation on N-type calcium channel., Front Pharmacol, 8, p. 302, DOI: 10.3389/fphar.2017.00302", "listPosition" : 15, "doi" : "10.3389/fphar.2017.00302", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202761, "link" : "/api/reference/36202761", "label" : "16. Pabba 2014: NMDA receptors are upregulated and trafficked to the plasma membrane after sigma-1 receptor activation in the rat hippocampus., J Neurosci, 34, p. 11325, DOI: 10.1523/JNEUROSCI.0458-14.2014", "listPosition" : 16, "doi" : "10.1523/JNEUROSCI.0458-14.2014", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202762, "link" : "/api/reference/36202762", "label" : "17. Sánchez-Blázquez 2014: The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases., Int J Neuropsychopharmacol, 17, p. 1943, DOI: 10.1017/S1461145714000029", "listPosition" : 17, "doi" : "10.1017/S1461145714000029", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202763, "link" : "/api/reference/36202763", "label" : "18. Rousseaux 2016: Sigma receptors [σRs]: biology in normal and diseased states., J Recept Signal Transduct Res, 36, p. 327", "listPosition" : 18, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202764, "link" : "/api/reference/36202764", "label" : "19. Su 2016: The sigma-1 receptor as a pluripotent modulator in living systems., Trends Pharmacol Sci, 37, p. 262, DOI: 10.1016/j.tips.2016.01.003", "listPosition" : 19, "doi" : "10.1016/j.tips.2016.01.003", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202765, "link" : "/api/reference/36202765", "label" : "20. Ye 2020: Small molecules selectively targeting sigma-1 receptor for the treatment of neurological diseases., J Med Chem, 63, p. 15187, DOI: 10.1021/acs.jmedchem.0c01192", "listPosition" : 20, "doi" : "10.1021/acs.jmedchem.0c01192", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202766, "link" : "/api/reference/36202766", "label" : "21. Reilmann 2019: European Huntington's Disease Network; Huntington Study Group investigators. Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study., Lancet Neurol, 18, p. 165, DOI: 10.1016/S1474-4422(18)30391-0", "listPosition" : 21, "doi" : "10.1016/S1474-4422(18)30391-0", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202767, "link" : "/api/reference/36202767", "label" : "22. Hampel 2020: A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2-73) Phase 2a clinical study., Alzheimers Dement (N Y), 6", "listPosition" : 22, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202768, "link" : "/api/reference/36202768", "label" : "23. Urfer 2014: Cutamesine Stroke Recovery Study Group. Phase II trial of the Sigma-1 receptor agonist cutamesine (SA4503) for recovery enhancement after acute ischemic stroke., Stroke, 45, p. 3304, DOI: 10.1161/STROKEAHA.114.005835", "listPosition" : 23, "doi" : "10.1161/STROKEAHA.114.005835", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202769, "link" : "/api/reference/36202769", "label" : "24. Schneider 2019: Alzheimer’s disease cooperative study TCAD study group. Safety and efficacy of edonerpic maleate for patients with mild to moderate alzheimer disease: a phase 2 randomized clinical trial., JAMA Neurol, 76, p. 1330, DOI: 10.1001/jamaneurol.2019.1868", "listPosition" : 24, "doi" : "10.1001/jamaneurol.2019.1868", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202770, "link" : "/api/reference/36202770", "label" : "25. Agha 2020: In vitro and in vivo sigma 1 receptor imaging studies in different disease states., RSC Med Chem, 12, p. 154, DOI: 10.1039/D0MD00186D", "listPosition" : 25, "doi" : "10.1039/D0MD00186D", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202771, "link" : "/api/reference/36202771", "label" : "26. Villard 2011: Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma 1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative., J Psychopharmacol, 25, p. 1101, DOI: 10.1177/0269881110379286", "listPosition" : 26, "doi" : "10.1177/0269881110379286", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202772, "link" : "/api/reference/36202772", "label" : "27. ClinicalTrials.gov. Prilenia, PRidopidine's Outcome On Function in Huntington Disease, PROOF-HD, 2023. Available online: https://clinicaltrials.gov/ct2/show/NCT04556656?term=pridopidine&draw=2&rank=2 (accessed on 1 September 2022).", "listPosition" : 27, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202773, "link" : "/api/reference/36202773", "label" : "28. ClinicalTrials.gov. M.D. Merit E. Cudkowicz, H. Massachusetts General, HEALEY ALS Platform Trial - Master Protocol, 2023. Available online: https://clinicaltrials.gov/ct2/show/NCT04615923?term=pridopidine&draw=1&rank=4 (accessed on 1 September 2022).", "listPosition" : 28, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202774, "link" : "/api/reference/36202774", "label" : "29. ClinicalTrials.gov. C. Anavex Life Sciences, L. Anavex Australia Pty, H. Anavex Germany Gmb, OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001, 2022. Available online: https://clinicaltrials.gov/ct2/show/NCT04575259?term=blarcamesine&draw=2&rank=1 (accessed on 1 September 2022).", "listPosition" : 29, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202775, "link" : "/api/reference/36202775", "label" : "30. ClinicalTrials.gov. C. Anavex Life Sciences, L. Anavex Australia Pty, H. Anavex Germany Gmb, ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome, 2022. Available online: https://clinicaltrials.gov/ct2/show/NCT04314934?term=blarcamesine&draw=1&rank=2 (accessed on 1 September 2022).", "listPosition" : 30, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202776, "link" : "/api/reference/36202776", "label" : "31. ClinicalTrials.gov. C. Anavex Life Sciences, L. Anavex Australia Pty, H. Anavex Germany Gmb, OLE of Phase 2b/3 Study ANAVEX2-73-AD-004, 2024. Available online: https://clinicaltrials.gov/ct2/show/NCT04304482?term=blarcamesine&draw=1&rank=3 (accessed on 1 September 2022).", "listPosition" : 31, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202777, "link" : "/api/reference/36202777", "label" : "32. ClinicalTrials.gov. C. M'S Science, SA4503 8-Week Study in Major Depressive Disorder (MDD). Available online: https://clinicaltrials.gov/ct2/show/NCT00551109?term=cutamesine&draw=2&rank=1 (accessed on 1 September 2022).", "listPosition" : 32, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202778, "link" : "/api/reference/36202778", "label" : "33. ClinicalTrials.gov. L. Fujifilm Toyama Chemical Co, Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD, 2023. Available online: https://clinicaltrials.gov/ct2/show/NCT04191486?term=T-817MA&draw=2&rank=1 (accessed on 1 September 2022).", "listPosition" : 33, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202779, "link" : "/api/reference/36202779", "label" : "34. Schmidt 2016: Crystal structure of the human σ1 receptor., Nature, 532, p. 527, DOI: 10.1038/nature17391", "listPosition" : 34, "doi" : "10.1038/nature17391", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202780, "link" : "/api/reference/36202780", "label" : "35. Schmidt 2018: Structural basis for σ1 receptor ligand recognition., Nat Struct Mol Biol, 25, p. 981, DOI: 10.1038/s41594-018-0137-2", "listPosition" : 35, "doi" : "10.1038/s41594-018-0137-2", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202781, "link" : "/api/reference/36202781", "label" : "36. Colabufo 2003: A new method for evaluating sigma(2) ligand activity in the isolated guinea-pig bladder., Naunyn Schmiedebergs Arch Pharmacol, 368, p. 106, DOI: 10.1007/s00210-003-0777-5", "listPosition" : 36, "doi" : "10.1007/s00210-003-0777-5", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202782, "link" : "/api/reference/36202782", "label" : "37. Ossa 2017: A Review of the Human Sigma-1 Receptor Structure., Adv Exp Med Biol, 964, p. 15, DOI: 10.1007/978-3-319-50174-1_3", "listPosition" : 37, "doi" : "10.1007/978-3-319-50174-1_3", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202783, "link" : "/api/reference/36202783", "label" : "38. Pettersen 2021: UCSF ChimeraX: Structure visualization for researchers, educators, and developers., Protein Sci, 30, p. 70, DOI: 10.1002/pro.3943", "listPosition" : 38, "doi" : "10.1002/pro.3943", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202784, "link" : "/api/reference/36202784", "label" : "39. Emberly 2004: Flexibility of beta-sheets: principal component analysis of database protein structures., Proteins, 55, p. 91, DOI: 10.1002/prot.10618", "listPosition" : 39, "doi" : "10.1002/prot.10618", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202785, "link" : "/api/reference/36202785", "label" : "40. Walker 1990: Sigma receptors: biology and function., Pharmacol Rev, 42, p. 355", "listPosition" : 40, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202786, "link" : "/api/reference/36202786", "label" : "41. Laggner 2005: Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening., J Med Chem, 48, p. 4754, DOI: 10.1021/jm049073+", "listPosition" : 41, "doi" : "10.1021/jm049073+", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202787, "link" : "/api/reference/36202787", "label" : "42. Righetti 2021: Exploring the selectivity profile of sigma receptor ligands by molecular docking and pharmacophore analyses., Med Chem, 17, p. 1151, DOI: 10.2174/1573406416666201106110611", "listPosition" : 42, "doi" : "10.2174/1573406416666201106110611", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202788, "link" : "/api/reference/36202788", "label" : "43. Largent 1987: Structural determinants of sigma receptor affinity., Mol Pharmacol, 32, p. 772", "listPosition" : 43, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202789, "link" : "/api/reference/36202789", "label" : "44. Gilligan 1992: Novel piperidine sigma receptor ligands as potential antipsychotic drugs., J Med Chem, 35, p. 4344, DOI: 10.1021/jm00101a012", "listPosition" : 44, "doi" : "10.1021/jm00101a012", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202790, "link" : "/api/reference/36202790", "label" : "45. Glennon RA, Ablordeppey SY, Ismaiel AM, el-Ashmawy MB, Fischer JB, Howie KB. Structural features important for sigma 1 receptor binding.J Med Chem. 1994;37(8):1214-1219. doi:10.1021/jm00034a020., DOI: 10.1021/jm00034a020", "listPosition" : 45, "doi" : "10.1021/jm00034a020", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202791, "link" : "/api/reference/36202791", "label" : "46. Zampieri 2009: Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma(1) receptor ligands based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives., J Med Chem, 52, p. 5380, DOI: 10.1021/jm900366z", "listPosition" : 46, "doi" : "10.1021/jm900366z", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202792, "link" : "/api/reference/36202792", "label" : "47. Fallica 2021: Recent advances in the development of sigma receptor ligands as cytotoxic agents: a medicinal chemistry perspective., J Med Chem, 64, p. 7926, DOI: 10.1021/acs.jmedchem.0c02265", "listPosition" : 47, "doi" : "10.1021/acs.jmedchem.0c02265", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202793, "link" : "/api/reference/36202793", "label" : "48. Weber 2017: Medicinal chemistry of σ1 receptor ligands: pharmacophore models, synthesis, structure affinity relationships, and pharmacological applications., Handb Exp Pharmacol, 244, p. 51, DOI: 10.1007/164_2017_33", "listPosition" : 48, "doi" : "10.1007/164_2017_33", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202794, "link" : "/api/reference/36202794", "label" : "49. Rossino 2020: New insights into the opening of the occluded ligand-binding pocket of sigma1 receptor: binding of a novel bivalent RC-33 derivative., J Chem Inf Model, 60, p. 756, DOI: 10.1021/acs.jcim.9b00649", "listPosition" : 49, "doi" : "10.1021/acs.jcim.9b00649", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202795, "link" : "/api/reference/36202795", "label" : "50. Meng 2022: An open-like conformation of the sigma-1 receptor reveals its ligand entry pathway., Nat Commun, 13, p. 1267, DOI: 10.1038/s41467-022-28946-w", "listPosition" : 50, "doi" : "10.1038/s41467-022-28946-w", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202796, "link" : "/api/reference/36202796", "label" : "51. Alon 2021: Structures of the σ2 receptor enable docking for bioactive ligand discovery., Nature, 600, p. 759, DOI: 10.1038/s41586-021-04175-x", "listPosition" : 51, "doi" : "10.1038/s41586-021-04175-x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202797, "link" : "/api/reference/36202797", "label" : "52. Greenfield 2020: Virtual screening for ligand discovery at the σ1 receptor., ACS Med Chem Lett, 11, p. 1555, DOI: 10.1021/acsmedchemlett.9b00314", "listPosition" : 52, "doi" : "10.1021/acsmedchemlett.9b00314", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202798, "link" : "/api/reference/36202798", "label" : "53. Elkholy 2022: Discovery of 3-(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligands., Chem Biol Drug Des, 100, p. 25, DOI: 10.1111/cbdd.14047", "listPosition" : 53, "doi" : "10.1111/cbdd.14047", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202799, "link" : "/api/reference/36202799", "label" : "54. Peng 2019: Comprehensive 3D-QSAR model predicts binding affinity of structurally diverse sigma 1 receptor ligands., J Chem Inf Model, 59, p. 486, DOI: 10.1021/acs.jcim.8b00521", "listPosition" : 54, "doi" : "10.1021/acs.jcim.8b00521", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202800, "link" : "/api/reference/36202800", "label" : "55. Dvorácskó 2021: Novel high affinity sigma-1 receptor ligands from minimal ensemble docking-based virtual screening., Int J Mol Sci, 22, p. 8112, DOI: 10.3390/ijms22158112", "listPosition" : 55, "doi" : "10.3390/ijms22158112", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202801, "link" : "/api/reference/36202801", "label" : "56. Vilner 1995: Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines., Cancer Res, 55, p. 408", "listPosition" : 56, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202802, "link" : "/api/reference/36202802", "label" : "57. Oyer 2019: Small-molecule modulators of sigma1 and sigma2/TMEM97 in the context of cancer: foundational concepts and emerging themes., Front Pharmacol, 10, p. 1141, DOI: 10.3389/fphar.2019.01141", "listPosition" : 57, "doi" : "10.3389/fphar.2019.01141", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202803, "link" : "/api/reference/36202803", "label" : "58. Kim 2017: Sigma1 pharmacology in the context of cancer., Handb Exp Pharmacol, 244, p. 237, DOI: 10.1007/164_2017_38", "listPosition" : 58, "doi" : "10.1007/164_2017_38", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202804, "link" : "/api/reference/36202804", "label" : "59. Huang 2014: Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy., Med Res Rev, 34, p. 532, DOI: 10.1002/med.21297", "listPosition" : 59, "doi" : "10.1002/med.21297", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202805, "link" : "/api/reference/36202805", "label" : "60. Zeng 2020: The biological function of sigma-2 receptor/TMEM97 and its utility in PET imaging studies in cancer., Cancers (Basel), 12, p. 1877, DOI: 10.3390/cancers12071877", "listPosition" : 60, "doi" : "10.3390/cancers12071877", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202806, "link" : "/api/reference/36202806", "label" : "61. Crottès 2011: Sig1R protein regulates hERG channel expression through a post-translational mechanism in leukemic cells., J Biol Chem, 286, p. 27947, DOI: 10.1074/jbc.M111.226738", "listPosition" : 61, "doi" : "10.1074/jbc.M111.226738", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202807, "link" : "/api/reference/36202807", "label" : "62. Pontisso 2021: Role of sigma-1 receptor in calcium modulation: possible involvement in cancer., Genes (Basel), 12, p. 139, DOI: 10.3390/genes12020139", "listPosition" : 62, "doi" : "10.3390/genes12020139", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202808, "link" : "/api/reference/36202808", "label" : "63. Gueguinou 2017: The SigmaR1 chaperone drives breast and colorectal cancer cell migration by tuning SK3-dependent Ca2+ homeostasis., Oncogene, 36, p. 3640, DOI: 10.1038/onc.2016.501", "listPosition" : 63, "doi" : "10.1038/onc.2016.501", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202809, "link" : "/api/reference/36202809", "label" : "64. Zeng 2012: Sigma-2 ligands induce tumour cell death by multiple signalling pathways., Br J Cancer, 106, p. 693, DOI: 10.1038/bjc.2011.602", "listPosition" : 64, "doi" : "10.1038/bjc.2011.602", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202810, "link" : "/api/reference/36202810", "label" : "65. Zeng 2019: TMEM97 and PGRMC1 do not mediate sigma-2 ligand-induced cell death., Cell Death Discov, 5, p. 58, DOI: 10.1038/s41420-019-0141-2", "listPosition" : 65, "doi" : "10.1038/s41420-019-0141-2", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202811, "link" : "/api/reference/36202811", "label" : "66. Abatematteo 2021: σ2 receptor and its role in cancer with focus on a multitarget directed ligand (MTDL) approach., Molecules, 26, p. 3743, DOI: 10.3390/molecules26123743", "listPosition" : 66, "doi" : "10.3390/molecules26123743", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202812, "link" : "/api/reference/36202812", "label" : "67. Niso 2013: Sigma-2 receptor agonists as possible antitumor agents in resistant tumors: hints for collateral sensitivity., ChemMedChem, 8, p. 2026, DOI: 10.1002/cmdc.201300291", "listPosition" : 67, "doi" : "10.1002/cmdc.201300291", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202813, "link" : "/api/reference/36202813", "label" : "68. Romeo 2021: Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity., Molecules, 26, p. 3860, DOI: 10.3390/molecules26133860", "listPosition" : 68, "doi" : "10.3390/molecules26133860", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202814, "link" : "/api/reference/36202814", "label" : "69. Georgiadis 2017: Sigma receptor (σR) ligands with antiproliferative and anticancer activity., Molecules, 22, p. 1408, DOI: 10.3390/molecules22091408", "listPosition" : 69, "doi" : "10.3390/molecules22091408", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202815, "link" : "/api/reference/36202815", "label" : "70. Cantonero 2020: NO1, a new sigma 2 receptor/TMEM97 fluorescent ligand, downregulates SOCE and promotes apoptosis in the triple negative breast cancer cell lines., Cancers (Basel), 12, p. 257, DOI: 10.3390/cancers12020257", "listPosition" : 70, "doi" : "10.3390/cancers12020257", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202816, "link" : "/api/reference/36202816", "label" : "71. Listro 2020: Exploring the RC-106 chemical space: design and synthesis of novel (E)-1-(3-arylbut-2-en-1-yl)-4-(substituted) piperazine derivatives as potential anticancer agents., Front Chem, 8, p. 495, DOI: 10.3389/fchem.2020.00495", "listPosition" : 71, "doi" : "10.3389/fchem.2020.00495", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202817, "link" : "/api/reference/36202817", "label" : "72. Asong 2019: New analogs of SYA013 as sigma-2 ligands with anticancer activity., Bioorg Med Chem, 27, p. 2629, DOI: 10.1016/j.bmc.2019.04.012", "listPosition" : 72, "doi" : "10.1016/j.bmc.2019.04.012", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202818, "link" : "/api/reference/36202818", "label" : "73. Longhitano 2017: Sigma-1 and Sigma-2 receptor ligands induce apoptosis and autophagy but have opposite effect on cell proliferation in uveal melanoma., Oncotarget, 8, p. 91099, DOI: 10.18632/oncotarget.19556", "listPosition" : 73, "doi" : "10.18632/oncotarget.19556", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202819, "link" : "/api/reference/36202819", "label" : "74. Česen 2013: Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomes., Cell Death Dis, 4", "listPosition" : 74, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202820, "link" : "/api/reference/36202820", "label" : "75. Ostenfeld 2005: Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress., Cancer Res, 65, p. 8975, DOI: 10.1158/0008-5472.CAN-05-0269", "listPosition" : 75, "doi" : "10.1158/0008-5472.CAN-05-0269", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202821, "link" : "/api/reference/36202821", "label" : "76. Ma 2016: Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells., Cell Death Dis, 7, DOI: 10.1038/cddis.2016.208", "listPosition" : 76, "doi" : "10.1038/cddis.2016.208", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202822, "link" : "/api/reference/36202822", "label" : "77. Spruce 2004: Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo., Cancer Res, 64, p. 4875, DOI: 10.1158/0008-5472.CAN-03-3180", "listPosition" : 77, "doi" : "10.1158/0008-5472.CAN-03-3180", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202823, "link" : "/api/reference/36202823", "label" : "78. Kopp 2021: Novel σ1 antagonists designed for tumor therapy: Structure - activity relationships of aminoethyl substituted cyclohexanes., Eur J Med Chem, 210, DOI: 10.1016/j.ejmech.2020.112950", "listPosition" : 78, "doi" : "10.1016/j.ejmech.2020.112950", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202824, "link" : "/api/reference/36202824", "label" : "79. Zeng 2014: Functional assays to define agonists and antagonists of the sigma-2 receptor., Anal Biochem, 448, p. 68, DOI: 10.1016/j.ab.2013.12.008", "listPosition" : 79, "doi" : "10.1016/j.ab.2013.12.008", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202825, "link" : "/api/reference/36202825", "label" : "80. Yano 2018: Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays., Neuropharmacology, 133, p. 264, DOI: 10.1016/j.neuropharm.2018.01.042", "listPosition" : 80, "doi" : "10.1016/j.neuropharm.2018.01.042", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202826, "link" : "/api/reference/36202826", "label" : "81. Cobos 2005: Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma 1 receptors of guinea pig brain., Synapse, 55, p. 192, DOI: 10.1002/syn.20103", "listPosition" : 81, "doi" : "10.1002/syn.20103", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202827, "link" : "/api/reference/36202827", "label" : "82. Hayashi 2007: Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival., Cell, 131, p. 596, DOI: 10.1016/j.cell.2007.08.036", "listPosition" : 82, "doi" : "10.1016/j.cell.2007.08.036", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202828, "link" : "/api/reference/36202828", "label" : "83. Chien 1995: Sigma antagonists potentiate opioid analgesia in rats., Neurosci Lett, 190, p. 137, DOI: 10.1016/0304-3940(95)11504-P", "listPosition" : 83, "doi" : "10.1016/0304-3940(95)11504-P", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202829, "link" : "/api/reference/36202829", "label" : "84. Shaghaghi 2021: Current development of sigma-2 receptor radioligands as potential tumor imaging agents., Bioorg Chem, 115, DOI: 10.1016/j.bioorg.2021.105163", "listPosition" : 84, "doi" : "10.1016/j.bioorg.2021.105163", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202830, "link" : "/api/reference/36202830", "label" : "85. Shen 2017: Visualizing Nerve Injury in a Neuropathic Pain Model with [18F]FTC-146 PET/MRI., Theranostics, 7, p. 2794, DOI: 10.7150/thno.19378", "listPosition" : 85, "doi" : "10.7150/thno.19378", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202831, "link" : "/api/reference/36202831", "label" : "86. Bacin 1998: Clinical study of [123I] N-(2-diethylaminoethyl)-4-iodobenzamide in the diagnosis of primary and metastatic ocular melanoma., Acta Ophthalmol Scand, 76, p. 56, DOI: 10.1034/j.1600-0420.1998.760110.x", "listPosition" : 86, "doi" : "10.1034/j.1600-0420.1998.760110.x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202832, "link" : "/api/reference/36202832", "label" : "87. Caveliers 2002: Sigma receptor scintigraphy with N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide of patients with suspected primary breast cancer: first clinical results., J Nucl Med, 43, p. 1647", "listPosition" : 87, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202833, "link" : "/api/reference/36202833", "label" : "88. Shen 2017: Radiosynthesis and first-in-human PET/MRI evaluation with clinical-grade [18F]FTC-146., Mol Imaging Biol, 19, p. 779, DOI: 10.1007/s11307-017-1064-z", "listPosition" : 88, "doi" : "10.1007/s11307-017-1064-z", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202834, "link" : "/api/reference/36202834", "label" : "89. Rui 2016: Synthesis and biological evaluation of new aryl-alkyl(alkenyl)-4-benzylpiperidines, novel Sigma Receptor (SR) modulators, as potential anticancer-agents., Eur J Med Chem, 124, p. 649, DOI: 10.1016/j.ejmech.2016.08.067", "listPosition" : 89, "doi" : "10.1016/j.ejmech.2016.08.067", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202835, "link" : "/api/reference/36202835", "label" : "90. Mach RH, Smith CR, al-Nabulsi I, Whirrett BR, Childers SR, Wheeler KT. Sigma 2 receptors as potential biomarkers of proliferation in breast cancer.Cancer Res. 1997;57(1):156-161.", "listPosition" : 90, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202836, "link" : "/api/reference/36202836", "label" : "91. Wheeler 2000: Sigma-2 receptors as a biomarker of proliferation in solid tumours., Br J Cancer, 82, p. 1223, DOI: 10.1054/bjoc.1999.1067", "listPosition" : 91, "doi" : "10.1054/bjoc.1999.1067", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202837, "link" : "/api/reference/36202837", "label" : "92. Jensen 2017: Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo., BMC Cancer, 17, p. 178, DOI: 10.1186/s12885-017-3162-3", "listPosition" : 92, "doi" : "10.1186/s12885-017-3162-3", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202838, "link" : "/api/reference/36202838", "label" : "93. Hornick 2010: The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine., Mol Cancer, 9, p. 298, DOI: 10.1186/1476-4598-9-298", "listPosition" : 93, "doi" : "10.1186/1476-4598-9-298", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202839, "link" : "/api/reference/36202839", "label" : "94. Casellas 2004: SR31747A: a peripheral sigma ligand with potent antitumor activities., Anticancer Drugs, 15, p. 113, DOI: 10.1097/00001813-200402000-00003", "listPosition" : 94, "doi" : "10.1097/00001813-200402000-00003", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202840, "link" : "/api/reference/36202840", "label" : "95. Bai 2017: Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells., Biochem Biophys Res Commun, 491, p. 919, DOI: 10.1016/j.bbrc.2017.07.136", "listPosition" : 95, "doi" : "10.1016/j.bbrc.2017.07.136", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202841, "link" : "/api/reference/36202841", "label" : "96. Bai 2019: Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells., J Cell Mol Med, 23, p. 7349, DOI: 10.1111/jcmm.14594", "listPosition" : 96, "doi" : "10.1111/jcmm.14594", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202842, "link" : "/api/reference/36202842", "label" : "97. Tyler 2017: Correction to “classics in chemical neuroscience: haloperidol”., ACS Chem Neurosci, 8, p. 1429, DOI: 10.1021/acschemneuro.7b00172", "listPosition" : 97, "doi" : "10.1021/acschemneuro.7b00172", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202843, "link" : "/api/reference/36202843", "label" : "98. Dichiara 2017: Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents., Future Med Chem, 9, p. 1749, DOI: 10.4155/fmc-2017-0064", "listPosition" : 98, "doi" : "10.4155/fmc-2017-0064", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202844, "link" : "/api/reference/36202844", "label" : "99. Sozio 2015: Haloperidol metabolite II prodrug: asymmetric synthesis and biological evaluation on rat C6 glioma cells., Eur J Med Chem, 90, p. 1, DOI: 10.1016/j.ejmech.2014.11.012", "listPosition" : 99, "doi" : "10.1016/j.ejmech.2014.11.012", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202845, "link" : "/api/reference/36202845", "label" : "100. Bowen 1990: Metabolites of haloperidol display preferential activity at sigma receptors compared to dopamine D-2 receptors., Eur J Pharmacol, 177, p. 111, DOI: 10.1016/0014-2999(90)90260-D", "listPosition" : 100, "doi" : "10.1016/0014-2999(90)90260-D", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202846, "link" : "/api/reference/36202846", "label" : "101. Vilner 1993: Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture., Eur J Pharmacol, 244, p. 199, DOI: 10.1016/0922-4106(93)90029-9", "listPosition" : 101, "doi" : "10.1016/0922-4106(93)90029-9", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202847, "link" : "/api/reference/36202847", "label" : "102. Wang 2004: Expression of sigma 1 receptor in human breast cancer., Breast Cancer Res Treat, 87, p. 205, DOI: 10.1007/s10549-004-6590-0", "listPosition" : 102, "doi" : "10.1007/s10549-004-6590-0", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202848, "link" : "/api/reference/36202848", "label" : "103. Brent 1995: Sigma binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture., Eur J Pharmacol, 278, p. 151, DOI: 10.1016/0014-2999(95)00115-2", "listPosition" : 103, "doi" : "10.1016/0014-2999(95)00115-2", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202849, "link" : "/api/reference/36202849", "label" : "104. Brent 1996: The sigma receptor ligand, reduced haloperidol, induces apoptosis and increases intracellular-free calcium levels [Ca2+]i in colon and mammary adenocarcinoma cells., Biochem Biophys Res Commun, 219, p. 219, DOI: 10.1006/bbrc.1996.0208", "listPosition" : 104, "doi" : "10.1006/bbrc.1996.0208", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202850, "link" : "/api/reference/36202850", "label" : "105. Nordenberg 2005: Anti-proliferative activity of haloperidol in B16 mouse and human SK-MEL-28 melanoma cell lines., Int J Oncol, 27, p. 1097", "listPosition" : 105, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202851, "link" : "/api/reference/36202851", "label" : "106. Marrazzo 2011: Antiproliferative activity of phenylbutyrate ester of haloperidol metabolite II [(±)-MRJF4] in prostate cancer cells., Eur J Med Chem, 46, p. 433, DOI: 10.1016/j.ejmech.2010.10.012", "listPosition" : 106, "doi" : "10.1016/j.ejmech.2010.10.012", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202852, "link" : "/api/reference/36202852", "label" : "107. Barbaraci 2021: Haloperidol metabolite II valproate ester (S)-(-)-MRJF22: preliminary studies as a potential multifunctional agent against uveal melanoma., J Med Chem, 64, p. 13622, DOI: 10.1021/acs.jmedchem.1c00995", "listPosition" : 107, "doi" : "10.1021/acs.jmedchem.1c00995", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202853, "link" : "/api/reference/36202853", "label" : "108. Ablordeppey 2008: Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one., Bioorg Med Chem, 16, p. 7291, DOI: 10.1016/j.bmc.2008.06.030", "listPosition" : 108, "doi" : "10.1016/j.bmc.2008.06.030", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202854, "link" : "/api/reference/36202854", "label" : "109. Al-Ghanim 2019: SYA 013 analogs as moderately selective sigma-2 (σ2) ligands: Structure-affinity relationship studies., Bioorg Med Chem, 27, p. 2421, DOI: 10.1016/j.bmc.2019.01.035", "listPosition" : 109, "doi" : "10.1016/j.bmc.2019.01.035", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202855, "link" : "/api/reference/36202855", "label" : "110. Asong 2020: A mechanistic investigation on the anticancer properties of SYA013, a homopiperazine analogue of haloperidol with activity against triple negative breast cancer cells., ACS Omega, 5, p. 32907, DOI: 10.1021/acsomega.0c03495", "listPosition" : 110, "doi" : "10.1021/acsomega.0c03495", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202856, "link" : "/api/reference/36202856", "label" : "111. Romeo 2021: Development of new benzylpiperazine derivatives as σ1 receptor ligands with in vivo antinociceptive and anti-allodynic effects., ACS Chem Neurosci, 12, p. 2003, DOI: 10.1021/acschemneuro.1c00106", "listPosition" : 111, "doi" : "10.1021/acschemneuro.1c00106", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202857, "link" : "/api/reference/36202857", "label" : "112. Wilson 2022: Examination of the novel sigma-1 receptor antagonist, SI 1/28, for antinociceptive and anti-allodynic efficacy against multiple types of nociception with fewer liabilities of use., Int J Mol Sci, 23, p. 615, DOI: 10.3390/ijms23020615", "listPosition" : 112, "doi" : "10.3390/ijms23020615", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202858, "link" : "/api/reference/36202858", "label" : "113. Déciga-Campos 2020: Design and synthesis of N–(benzylpiperidinyl)–4–fluorobenzamide: A haloperidol analog that reduces neuropathic nociception via σ1 receptor antagonism., Life Sci, 245, DOI: 10.1016/j.lfs.2020.117348", "listPosition" : 113, "doi" : "10.1016/j.lfs.2020.117348", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202859, "link" : "/api/reference/36202859", "label" : "114. Arena 2016: New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation., Bioorg Med Chem, 24, p. 3149, DOI: 10.1016/j.bmc.2016.05.045", "listPosition" : 114, "doi" : "10.1016/j.bmc.2016.05.045", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202860, "link" : "/api/reference/36202860", "label" : "115. Intagliata 2019: Benzimidazolone-based selective σ2 receptor ligands: Synthesis and pharmacological evaluation., Eur J Med Chem, 165, p. 250, DOI: 10.1016/j.ejmech.2019.01.019", "listPosition" : 115, "doi" : "10.1016/j.ejmech.2019.01.019", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202861, "link" : "/api/reference/36202861", "label" : "116. Intagliata 2020: Discovery of a highly selective sigma-2 receptor ligand, 1-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one (CM398), with drug-like properties and antinociceptive effects in vivo., AAPS J, 22, p. 94, DOI: 10.1208/s12248-020-00472-x", "listPosition" : 116, "doi" : "10.1208/s12248-020-00472-x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202862, "link" : "/api/reference/36202862", "label" : "117. Weber 2014: Synthesis, pharmacological evaluation, and σ1 receptor interaction analysis of hydroxyethyl substituted piperazines., J Med Chem, 57, p. 2884, DOI: 10.1021/jm401707t", "listPosition" : 117, "doi" : "10.1021/jm401707t", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202863, "link" : "/api/reference/36202863", "label" : "118. Weber 2016: Rigidity versus flexibility: is this an issue in σ1 receptor ligand affinity and activity?., J Med Chem, 59, p. 5505, DOI: 10.1021/acs.jmedchem.6b00585", "listPosition" : 118, "doi" : "10.1021/acs.jmedchem.6b00585", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202864, "link" : "/api/reference/36202864", "label" : "119. Korpis 2014: Cytotoxic activities of hydroxyethyl piperazine-based σ receptor ligands on cancer cells alone and in combination with melphalan, PB28 and haloperidol., Pharmazie, 69, p. 917", "listPosition" : 119, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202865, "link" : "/api/reference/36202865", "label" : "120. Korpis 2014: Involvement of apoptosis and autophagy in the death of RPMI 8226 multiple myeloma cells by two enantiomeric sigma receptor ligands., Bioorg Med Chem, 22, p. 221, DOI: 10.1016/j.bmc.2013.11.033", "listPosition" : 120, "doi" : "10.1016/j.bmc.2013.11.033", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202866, "link" : "/api/reference/36202866", "label" : "121. Abate 2011: 1-Cyclohexyl-4-(4-arylcyclohexyl)piperazines: Mixed σ and human Δ(8)-Δ(7) sterol isomerase ligands with antiproliferative and P-glycoprotein inhibitory activity., ChemMedChem, 6, p. 73, DOI: 10.1002/cmdc.201000371", "listPosition" : 121, "doi" : "10.1002/cmdc.201000371", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202867, "link" : "/api/reference/36202867", "label" : "122. Berardi 2008: Novel 4-(4-aryl)cyclohexyl-1-(2-pyridyl)piperazines as Delta(8)-Delta(7) sterol isomerase (emopamil binding protein) selective ligands with antiproliferative activity., J Med Chem, 51, p. 7523, DOI: 10.1021/jm800965b", "listPosition" : 122, "doi" : "10.1021/jm800965b", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202868, "link" : "/api/reference/36202868", "label" : "123. Colabufo 2004: Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines., Naunyn Schmiedebergs Arch Pharmacol, 370, p. 106, DOI: 10.1007/s00210-004-0961-2", "listPosition" : 123, "doi" : "10.1007/s00210-004-0961-2", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202869, "link" : "/api/reference/36202869", "label" : "124. Hornick 2012: Lysosomal membrane permeabilization is an early event in Sigma-2 receptor ligand mediated cell death in pancreatic cancer., J Exp Clin Cancer Res, 31, p. 41, DOI: 10.1186/1756-9966-31-41", "listPosition" : 124, "doi" : "10.1186/1756-9966-31-41", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202870, "link" : "/api/reference/36202870", "label" : "125. Franchini 2017: Structure-Activity Relationships within a Series of σ1 and σ2 Receptor Ligands: Identification of a σ2 Receptor Agonist (BS148) with Selective Toxicity against Metastatic Melanoma., ChemMedChem, 12, p. 1893, DOI: 10.1002/cmdc.201700427", "listPosition" : 125, "doi" : "10.1002/cmdc.201700427", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202871, "link" : "/api/reference/36202871", "label" : "126. Zampieri 2018: New piperidine-based derivatives as sigma receptor ligands. Synthesis and pharmacological evaluation., Bioorg Med Chem Lett, 28, p. 3206, DOI: 10.1016/j.bmcl.2018.08.016", "listPosition" : 126, "doi" : "10.1016/j.bmcl.2018.08.016", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202872, "link" : "/api/reference/36202872", "label" : "127. Pati 2018: Multifunctional thiosemicarbazones and deconstructed analogues as a strategy to study the involvement of metal chelation, Sigma-2 (σ2) receptor and P-gp protein in the cytotoxic action: In vitro and in vivo activity in pancreatic tumors., Eur J Med Chem, 144, p. 359, DOI: 10.1016/j.ejmech.2017.12.024", "listPosition" : 127, "doi" : "10.1016/j.ejmech.2017.12.024", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202873, "link" : "/api/reference/36202873", "label" : "128. Utech 2011: Synthesis of 4-(aminoalkyl) substituted 1,3-dioxanes as potent NMDA and σ receptor antagonists., Eur J Med Chem, 46, p. 2157, DOI: 10.1016/j.ejmech.2011.02.070", "listPosition" : 128, "doi" : "10.1016/j.ejmech.2011.02.070", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202874, "link" : "/api/reference/36202874", "label" : "129. Kopp 2021: Chemoenzymatic synthesis of 2,6-disubstituted tetrahydropyrans with high σ1 receptor affinity, antitumor and analgesic activity., Eur J Med Chem, 219, DOI: 10.1016/j.ejmech.2021.113443", "listPosition" : 129, "doi" : "10.1016/j.ejmech.2021.113443", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202875, "link" : "/api/reference/36202875", "label" : "130. Holtschulte 2022: Synthesis of Aminoethyl-Substituted Piperidine Derivatives as σ1 Receptor Ligands with Antiproliferative Properties., ChemMedChem, 17, DOI: 10.1002/cmdc.202100735", "listPosition" : 130, "doi" : "10.1002/cmdc.202100735", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202876, "link" : "/api/reference/36202876", "label" : "131. Marrazzo 2002: Synthesis of (+)- and (-)-cis-2-[(1-adamantylamino)-methyl]-1-phenylcyclopropane derivatives as high affinity probes for sigma1 and sigma2 binding sites., Farmaco, 57, p. 45, DOI: 10.1016/S0014-827X(01)01170-3", "listPosition" : 131, "doi" : "10.1016/S0014-827X(01)01170-3", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202877, "link" : "/api/reference/36202877", "label" : "132. Intagliata 2020: Exploring 1-adamantanamine as an alternative amine moiety for metabolically labile azepane ring in newly synthesized benzo[d]thiazol-2(3H)one σ receptor ligands., Med Chem Res, 29, p. 1697, DOI: 10.1007/s00044-020-02597-2", "listPosition" : 132, "doi" : "10.1007/s00044-020-02597-2", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202878, "link" : "/api/reference/36202878", "label" : "133. Ronsisvalle 2000: Substituted 1-phenyl-2-cyclopropylmethylamines with high affinity and selectivity for sigma sites., Bioorg Med Chem, 8, p. 1503, DOI: 10.1016/S0968-0896(00)00072-9", "listPosition" : 133, "doi" : "10.1016/S0968-0896(00)00072-9", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202879, "link" : "/api/reference/36202879", "label" : "134. Riganas 2012: Synthesis, σ, σ-receptors binding affinity and antiproliferative action of new C1-substituted adamantanes., Bioorg Med Chem, 20, p. 3323, DOI: 10.1016/j.bmc.2012.03.038", "listPosition" : 134, "doi" : "10.1016/j.bmc.2012.03.038", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202880, "link" : "/api/reference/36202880", "label" : "135. Riganas 2012: New adamantane derivatives with sigma affinity and antiproliferative activity., Med Chem, 8, p. 569, DOI: 10.2174/157340612801216201", "listPosition" : 135, "doi" : "10.2174/157340612801216201", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202881, "link" : "/api/reference/36202881", "label" : "136. Riganas 2012: New adamantane phenylalkylamines with σ-receptor binding affinity and anticancer activity, associated with putative antagonism of neuropathic pain., J Med Chem, 55, p. 10241, DOI: 10.1021/jm3013008", "listPosition" : 136, "doi" : "10.1021/jm3013008", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202882, "link" : "/api/reference/36202882", "label" : "137. Rossi 2017: Gaining in pan-affinity towards sigma 1 and sigma 2 receptors. SAR studies on arylalkylamines., Bioorg Med Chem, 25, p. 11, DOI: 10.1016/j.bmc.2016.10.005", "listPosition" : 137, "doi" : "10.1016/j.bmc.2016.10.005", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202883, "link" : "/api/reference/36202883", "label" : "138. Tesei 201910490: Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer., Front Pharmacol", "listPosition" : 138, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202884, "link" : "/api/reference/36202884", "label" : "139. Cortesi 2020: Pan-sigma receptor modulator RC-106 induces terminal unfolded protein response in in vitro pancreatic cancer model., Int J Mol Sci, 21, p. 9012, DOI: 10.3390/ijms21239012", "listPosition" : 139, "doi" : "10.3390/ijms21239012", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202885, "link" : "/api/reference/36202885", "label" : "140. Cirino 2019: Characterization of sigma 1 receptor antagonist CM-304 and its analog, AZ-66: novel therapeutics against allodynia and induced pain., Front Pharmacol, 10, p. 678, DOI: 10.3389/fphar.2019.00678", "listPosition" : 140, "doi" : "10.3389/fphar.2019.00678", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202886, "link" : "/api/reference/36202886", "label" : "141. Nicholson 2019: Divergent cytotoxic and metabolically stimulative functions of sigma-2 receptors: structure-activity relationships of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79) derivatives., J Pharmacol Exp Ther, 368, p. 272, DOI: 10.1124/jpet.118.253484", "listPosition" : 141, "doi" : "10.1124/jpet.118.253484", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202887, "link" : "/api/reference/36202887", "label" : "142. Liu 2021: Identification and characterization of MAM03055A: A novel bivalent sigma-2 receptor/TMEM97 ligand with cytotoxic activity., Eur J Pharmacol, 906, DOI: 10.1016/j.ejphar.2021.174263", "listPosition" : 142, "doi" : "10.1016/j.ejphar.2021.174263", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202888, "link" : "/api/reference/36202888", "label" : "143. Romeo 2019: Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands., Eur J Med Chem, 174, p. 226, DOI: 10.1016/j.ejmech.2019.04.056", "listPosition" : 143, "doi" : "10.1016/j.ejmech.2019.04.056", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 36202889, "link" : "/api/reference/36202889", "label" : "144. Abate 2011: Arylamides hybrids of two high-affinity σ2 receptor ligands as tools for the development of PET radiotracers., Eur J Med Chem, 46, p. 4733, DOI: 10.1016/j.ejmech.2011.05.057", "listPosition" : 144, "doi" : "10.1016/j.ejmech.2011.05.057", "published" : false, "snippet" : true } ], "hasCitationDuplums" : false, "userChangeableUntil" : "2023-02-20T08:01:32.865+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 9, "ownerInstituteCount" : 23, "directInstituteCount" : 0, "authorCount" : 9, "contributorCount" : 0, "hasQualityFactor" : true, "link" : "/api/publication/33286383", "label" : "Fallica Antonino N. et al. Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects. (2022) BIOORGANIC & MEDICINAL CHEMISTRY 0968-0896 1464-3391 73", "template" : "